GK PHARMA ApS: Financial statements 2025
CVR: 81267316
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
GK PHARMA ApS (CVR 81267316) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 5,931,212 and a net result of DKK 2,646,889 compared with DKK 954,244 the year before. That is an increase of 55.2% compared with the year before. Equity in the 2025 report amounted to DKK 4,029,041. The solvency ratio was 33.8%. The company had 22 employees in the financial year.
- Gross Profit
- DKK 5,931,212
- Profit/Loss
- DKK 2,646,889
- Equity
- DKK 4,029,041
- Total Assets
- DKK 11,909,342
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 5.9 mio. | 2.6 mio. | 4 mio. | 22 |
| 2024 | - | 3.8 mio. | 954 t. | 2.2 mio. | 18 |
| 2023 | - | 3.2 mio. | 862 t. | 2.1 mio. | 15 |
| 2022 | - | 3.9 mio. | 1 mio. | 1.3 mio. | 16 |
| 2021 | 16.7 mio. | 4.8 mio. | 1.6 mio. | 1.8 mio. | - |
Official annual report
How creditworthy is GK PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
GK PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 3,822,556, and the net result was DKK 954,244.
About GK PHARMA ApS
GK PHARMA ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 1977. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named DUNCANS, ERIK V. THOMSEN ApS and ERIK V. THOMSEN ApS. The management consists of Klaus Groth. The board consists of Dorthe Groth (chair) and Klaus Groth. The company is owned by Salvefabrikken ApS. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 5,931,212 and a net result of DKK 2,646,889 compared with DKK 954,244 the year before. Equity in the 2025 report amounted to DKK 4,029,041.